Ariadna Rando Segura Institutions of which they are part Main researcher Microbiology Vall Hebron Institut de Recerca Biologist Clinical Laboratories Cross-departmental services Email Ariadna Rando Segura Email Institutions of which they are part Main researcher Microbiology Vall Hebron Institut de Recerca Biologist Clinical Laboratories Cross-departmental services
Research lines Hepatitis The liver disease unit is focused on studying the viral hepatitis with a special emphasis on the basic virology, its translational applications, and the evaluation of new serological and virological markers for patient follow-up thanks to the collaboration with both industry and basic/clinical research groups. Moreover, it is also centred in contributing to the elimination of the hepatitis C virus (HCV), in evaluating HDV epidemiology in high prevalence populations, in inspecting viral variability to determine its relationship with disease progression, immune activation and the development of new therapeutic gene therapy strategies. Of note, the unit is also interested in studying HBV and HDV interaction in collaboration with the gene therapy group of CIMA-University of Navarra. IP: Ariadna Rando Segura Projects Grup de Recerca en Microbiologia de Hospital Universitari Vall d'Hebron IP: Juan Jose Gonzalez Lopez Collaborators: María Nieves Larrosa Escartin, Maria Belén Viñado Perez, Gema Codina Grau, Virginia Rodríguez Garrido, Andres Antón Pagarolas, Juliana Esperalba Esquerra, Ariadna Rando Segura, Alba Mir Cros, Yannick Hoyos Mallecot, Joan Joseph Munné, Tomàs Pumarola Suñé, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Albert Moreno Mingorance, Maria Piñana Moro, Aroa Silgado Gimenez, Elena Sulleiro Igual, Lidia Goterris Bonet, Josep Roca Grande, Alejandra Gonzalez Sánchez, Narcís Saubí Roca, Jesus Trejo Zahinos Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 01129 Duration: 01/01/2022 - 30/06/2025 Optimización del algoritmo diagnóstico para el cribado de infección por virus de la hepatitis D en la población atendida en el área de cobertura de la sanidad pública de la ciudad de Barcelona. IP: Ariadna Rando Segura Collaborators: Maria Buti Ferret, David Tabernero Caellas, Maria Francesca Cortese Funding agency: GILEAD SCIENCES SLU Funding: 27000 Reference: GILEAD/HEPATITIS/2022/RANDO Duration: 22/02/2023 - 21/02/2025 Identificación de marcadores de diagnóstico y pronóstico de carcinoma hepatocelular (HCC) en vesiculas extracelulares, mediante un método mínimamente invasivo, basado en secuenciación masiva (NGS) IP: Josep Quer Sivila Collaborators: Itxarone Izaskun Bilbao Aguirre, Lluis Castells Fusté, Ariadna Rando Segura, Damir Garcia Cehic Funding agency: Instituto de Salud Carlos III Funding: 165770 Reference: PI19/00301 Duration: 01/01/2020 - 30/06/2023 Desarrollo de nuevas terapias basadas en microbiota intestinal mediante un enfoque polifásico (cultivo + ómicas) para el tratamiento de la hipertensión portal en esteatohepatitis no alcohólica IP: Macarena Simon-Talero Horga Collaborators: Ariadna Rando Segura Funding agency: Instituto de Salud Carlos III Funding: 111320 Reference: PI17/00310 Duration: 01/01/2018 - 30/06/2021 Pagination Current page 1 Page 2 Next page › Last page »
